GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$16.39
+0.31%Margins
Gross margin
100.0%
EBITDA margin
-653.7%
EBIT margin
-737.0%
Net margin
-637.0%
FCF margin
-640.1%
-44.5%
Return on equity
-36.2%
Return on assets
-45.3%
Return on invested capital
0.05x
Asset turnover
-$200.6M
Cash from operations
$3.56
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026